A new UK study led by Imperial College London, published in Archives of Disease in Childhood, finds that providing every school with spare adrenaline auto-injectors (AAIs) could improve emergency care for children and save the NHS at least £4.6 million a year. 

A master’s student in Allergy at the University of Southampton is inviting young people aged 16–18 years old to take part in a research study exploring the experiences of young people with food allergies as they move away from home.

A newly published study from the French Allergy-Vigilance Network (AVN), spanning over two decades from 2002 to 2023, has shed light on an important issue affecting many people who live with food allergies: serious reactions triggered by foods outside the

Researchers at the University of Southampton are inviting healthcare practitioners to take part in a research study to help prevent food allergy. This research is part of a doctorate project led by Karen Wright and funded by the Biomedical Research

For anyone living with food allergies—or caring for someone who does—the thought of experiencing a reaction at 30,000 feet can understandably trigger serious worry. People are well aware that help is far from being immediately available in the air, and

Anaphylm is a medicine being developed by Aquestive Therapeutics for the emergency treatment of serious allergic reactions, including anaphylaxis.

Researchers at the University of Southampton are inviting parents and caregivers of young infants to take part in a research study to help prevent food allergy in babies. This research is part of a doctorate project led by Karen Wright,

A new study using data from the European Anaphylaxis Registry has identified important changes in which tree nuts are most likely to cause serious allergic reactions (anaphylaxis) in children and adults across Europe. The results show that cashew nuts are

A new study, led by King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, has shown promising results, demonstrating that peanut oral immunotherapy (OIT) may be an effective treatment for adults with peanut allergies. The trial, known as